BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rouillard S, Lane NE. Hepatic osteodystrophy. Hepatology. 2001;33:301-307. [PMID: 11124849 DOI: 10.1053/jhep.2001.20533] [Cited by in Crossref: 85] [Cited by in F6Publishing: 79] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Goral V, Simsek M, Mete N. Hepatic osteodystrophy and liver cirrhosis. World J Gastroenterol. 2010;16:1639-1643. [PMID: 20355242 DOI: 10.3748/wjg.v16.i13.1639] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
2 Angulo P, Grandison GA, Fong DG, Keach JC, Lindor KD, Bjornsson E, Koch A. Bone disease in patients with primary sclerosing cholangitis. Gastroenterology 2011;140:180-8. [PMID: 20955707 DOI: 10.1053/j.gastro.2010.10.014] [Cited by in Crossref: 75] [Cited by in F6Publishing: 44] [Article Influence: 6.8] [Reference Citation Analysis]
3 Pusl T, Beuers U. Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy. Clin Rev Allergy Immunol. 2005;28:147-157. [PMID: 15879620 DOI: 10.1385/criai:] [Reference Citation Analysis]
4 Wagner D, Amrein K, Dimai HP, Kniepeiss D, Tscheliessnigg KH, Kornprat P, Dobnig H, Pieber T, Fahrleitner-pammer A. Ibandronate and Calcitriol Reduces Fracture Risk, Reverses Bone Loss, and Normalizes Bone Turnover After lTX. Transplantation 2012;93:331-6. [DOI: 10.1097/tp.0b013e31823f7f68] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
5 Crawford BA, Labio ED, Strasser SI, McCaughan GW. Vitamin D replacement for cirrhosis-related bone disease. Nat Clin Pract Gastroenterol Hepatol. 2006;3:689-699. [PMID: 17130879 DOI: 10.1038/ncpgasthep0637] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
6 Lo Re V 3rd, Lynn K, Stumm ER, Long J, Nezamzadeh MS, Baker JF, Hoofnagle AN, Kapalko AJ, Mounzer K, Zemel BS, Tebas P, Kostman JR, Leonard MB. Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women. J Infect Dis 2015;212:924-33. [PMID: 25754980 DOI: 10.1093/infdis/jiv147] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
7 Glasova H, Beuers U. Extrahepatic manifestations of cholestasis. Journal of Gastroenterology and Hepatology 2002;17:938-48. [DOI: 10.1046/j.1440-1746.2002.02717.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
8 Zhang W, Gong H, Su Z, Zhang X, Cao S. Risk factors associated with hepatic osteopathy in HBV related cirrhosis measured by liver stiffness: An Observational study. Medicine (Baltimore). 2019;98:e16628. [PMID: 31374030 DOI: 10.1097/md.0000000000016628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Kaya M, Işık D, Beştaş R, Evliyaoğlu O, Akpolat V, Büyükbayram H, Kaplan MA. Increased bone mineral density in patients with non-alcoholic steatohepatitis. World J Hepatol 2013;5:627-34. [PMID: 24303091 DOI: 10.4254/wjh.v5.i11.627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
10 Sanchez AJ, Aranda-Michel J. Liver disease and osteoporosis. Nutr Clin Pract. 2006;21:273-278. [PMID: 16772544 DOI: 10.1177/0115426506021003273] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
11 Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Sezaki H, Hosaka T, Kawamura Y, Yatsuji H, Hirakawa M. Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus. J Med Virol. 2010;82:390-395. [PMID: 20087925 DOI: 10.1002/jmv.21691] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
12 Hajiabbasi A, Shafaghi A, Fayazi HS, Shenavar Masooleh I, Hedayati Emami MH, Ghavidel Parsa P, Amir Maafi A. The factors affecting bone density in cirrhosis. Hepat Mon 2015;15:e26871. [PMID: 25977695 DOI: 10.5812/hepatmon.15(4)2015.26871] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
13 D???antiga L, Moniz C, Buxton-thomas M, Cheeseman P, Gray B, Abraha H, Baker AJ, Heaton ND, Rela M, Mieli-vergani G, Dhawan A. Bone mineral density and height gain in children with chronic cholestatic liver disease undergoing transplantation: . Transplantation 2002;73:1788-93. [DOI: 10.1097/00007890-200206150-00015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
14 Huang Z, Wei H, Cheng C, Yang S, Wang J, Liu X. Low bone mineral density in chronic hepatitis B virus infection: A case-control study. Pak J Med Sci 2017;33:457-61. [PMID: 28523056 DOI: 10.12669/pjms.332.12099] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
15 Lo Re V, Volk J, Newcomb CW, Yang YX, Freeman CP, Hennessy S, Kostman JR, Tebas P, Leonard MB, Localio AR. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection. Hepatology. 2012;56:1688-1698. [PMID: 22619086 DOI: 10.1002/hep.25866] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
16 Hofmann WP, Kronenberger B, Bojunga J, Stamm B, Herrmann E, Bücker A, Mihm U, von Wagner M, Zeuzem S, Sarrazin C. Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy. J Viral Hepat. 2008;15:790-796. [PMID: 18673425 DOI: 10.1111/j.1365-2893.2008.01038.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 0.2] [Reference Citation Analysis]
17 Ishimoto T, Suetoshi R, Cretin D, Hagihara K, Hashimoto J, Kobayashi A, Nakano T. Quantitative ultrasound (QUS) axial transmission method reflects anisotropy in micro-arrangement of apatite crystallites in human long bones: A study with 3-MHz-frequency ultrasound. Bone 2019;127:82-90. [DOI: 10.1016/j.bone.2019.05.034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Yurci A, Yucesoy M, Unluhizarci K, Torun E, Gursoy S, Baskol M, Guven K, Ozbakir O. Effects of testosterone gel treatment in hypogonadal men with liver cirrhosis. Clin Res Hepatol Gastroenterol. 2011;35:845-854. [PMID: 22074639 DOI: 10.1016/j.clinre.2011.09.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
19 Liu LU, Schiano TD. Long-term care of the liver transplant recipient. Clin Liver Dis. 2007;11:397-416. [PMID: 17606214 DOI: 10.1016/j.cld.2007.04.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
20 Bang CS, Shin IS, Lee SW, Kim JB, Baik GH, Suk KT, Yoon JH, Kim YS, Kim DJ. Osteoporosis and bone fractures in alcoholic liver disease: a meta-analysis. World J Gastroenterol 2015;21:4038-47. [PMID: 25852292 DOI: 10.3748/wjg.v21.i13.4038] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
21 Chandrasekaran V, Pasco JA, Stuart AL, Brennan-Olsen SL, Berk M, Hodge JM, Samarasinghe RM, Williams LJ. Anticonvulsant use and bone health in a population-based study of men and women: cross-sectional data from the Geelong Osteoporosis Study. BMC Musculoskelet Disord 2021;22:172. [PMID: 33573610 DOI: 10.1186/s12891-021-04042-w] [Reference Citation Analysis]
22 Bodingbauer M, Wekerle T, Pakrah B, Roschger P, Peck-Radosavljevic M, Silberhumer G, Grampp S, Rockenschaub S, Berlakovich G, Steininger R. Prophylactic bisphosphonate treatment prevents bone fractures after liver transplantation. Am J Transplant. 2007;7:1763-1769. [PMID: 17511759 DOI: 10.1111/j.1600-6143.2007.01844.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
23 Gorustovich AA, Espósito MA, Guglielmotti MB, Giglio MJ. Mandibular bone remodeling under a choline-deficient diet: a histomorphometric study in rats. J Periodontol 2003;74:831-7. [PMID: 12886993 DOI: 10.1902/jop.2003.74.6.831] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
24 Oya A, Umezu T, Ogawa R, Nishiwaki T, Niki Y, Nakamura M, Matsumoto M, Kanaji A. Short-Term Outcomes of Total Hip Arthroplasty after Liver Transplantation. Arthroplast Today 2021;8:11-4. [PMID: 33665276 DOI: 10.1016/j.artd.2021.01.001] [Reference Citation Analysis]
25 Ackerman Z, Weinreb M, Amir G, Pollak RD. Bone mineral metabolism and histomorphometry in rats with cholestatic liver disease. Liver. 2002;22:166-172. [PMID: 12028412 DOI: 10.1046/j.0106-9543.2002.01566.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
26 de Albuquerque Taveira AT, Fernandes MI, Galvão LC, Sawamura R, de Mello Vieira E, de Paula FJ. Impairment of bone mass development in children with chronic cholestatic liver disease. Clin Endocrinol (Oxf) 2007;66:518-23. [PMID: 17371469 DOI: 10.1111/j.1365-2265.2007.02765.x] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
27 Lim KB, Schiano TD. Long-term outcome after liver transplantation. Mt Sinai J Med. 2012;79:169-189. [PMID: 22499489 DOI: 10.1002/msj.21302] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
28 López-Larramona G, Lucendo AJ, González-Castillo S, Tenias JM. Hepatic osteodystrophy: An important matter for consideration in chronic liver disease. World J Hepatol. 2011;3:300-307. [PMID: 22216370 DOI: 10.4254/wjh.v3.i12.300] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.7] [Reference Citation Analysis]
29 Homchan K, Chaiwatanarat T, Udomsinprasert W, Chongsrisawat V, Poovorawan Y, Honsawek S. Low bone mineral density and the severity of cholestasis in biliary atresia. World J Hepatol 2017;9:746-51. [PMID: 28652893 DOI: 10.4254/wjh.v9.i16.746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
30 Byrne DD, Newcomb CW, Carbonari DM, Nezamzadeh MS, Leidl KB, Herlim M, Yang YX, Hennessy S, Kostman JR, Leonard MB, Localio AR, Lo Re V 3rd. Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfection. J Viral Hepat 2015;22:936-47. [PMID: 25754215 DOI: 10.1111/jvh.12398] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
31 Wariaghli G, Mounach A, Achemlal L, Benbaghdadi I, Aouragh A, Bezza A, El Maghraoui A. Osteoporosis in chronic liver disease: a case–control study. Rheumatol Int 2010;30:893-9. [DOI: 10.1007/s00296-009-1071-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
32 Schiefke I, Fach A, Wiedmann M, Aretin AV, Schenker E, Borte G, Wiese M, Moessner J. Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection. World J Gastroenterol. 2005;11:1843-1847. [PMID: 15793878 DOI: 10.3748/wjg.v11.i12.1843] [Cited by in CrossRef: 104] [Cited by in F6Publishing: 99] [Article Influence: 6.5] [Reference Citation Analysis]
33 Gaudio A, Lasco A, Morabito N, Atteritano M, Vergara C, Catalano A, Fries W, Trifiletti A, Frisina N. Hepatic osteodystrophy: Does the osteoprotegerin/receptor activator of nuclear factor-kB ligand systemplay a role? J Endocrinol Invest 2005;28:677-82. [DOI: 10.1007/bf03347549] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
34 Yang J, Sharma A, Shi Q, Anastos K, Cohen MH, Golub ET, Gustafson D, Merenstein D, Mack WJ, Tien PC, Nieves JW, Yin MT. Improved fracture prediction using different fracture risk assessment tool adjustments in HIV-infected women. AIDS 2018;32:1699-706. [PMID: 29762165 DOI: 10.1097/QAD.0000000000001864] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
35 Dong HV, Cortés YI, Shiau S, Yin MT. Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis. AIDS 2014;28:2119-31. [PMID: 24977441 DOI: 10.1097/QAD.0000000000000363] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 6.7] [Reference Citation Analysis]
36 Trauner M, Boyer JL. Cholestatic syndromes: . Current Opinion in Gastroenterology 2001;17:242-56. [DOI: 10.1097/00001574-200105000-00007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
37 Gorustovich A, Angeles Esposito M, Guglielmotti MB, Juan Giglio M. Periimplant Bone Healing under Experimental Hepatic Osteodystrophy Induced by a Choline-Deficient Diet: A Histomorphometric Study in Rats. Clin Implant Dent Rel Res 2003;5:124-9. [DOI: 10.1111/j.1708-8208.2003.tb00193.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
38 Choudhary NS, Tomar M, Chawla YK, Bhadada SK, Khandelwal N, Dhiman RK, Duseja A, Bhansali A. Hepatic osteodystrophy is common in patients with noncholestatic liver disease. Dig Dis Sci. 2011;56:3323-3327. [PMID: 21573732 DOI: 10.1007/s10620-011-1722-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
39 Mora S, Giacomet V, Viganò A, Maruca K, Capelli S, Nannini P, Zuccotti GV. Areal Bone Mineral Density in Pediatric Patients with Chronic Hepatitis B or Chronic Hepatitis C. Calcif Tissue Int 2014;95:218-21. [DOI: 10.1007/s00223-014-9884-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
40 Gasser RW. Cholestasis and metabolic bone disease - a clinical review. Wien Med Wochenschr. 2008;158:553-557. [PMID: 18998071 DOI: 10.1007/s10354-008-0594-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
41 D’antiga L, Ballan D, Luisetto G, Cillo U, Guariso G, Zancan L. Long-Term Outcome of Bone Mineral Density in Children who Underwent a Successful Liver Transplantation. Transplantation 2004;78:899-903. [DOI: 10.1097/01.tp.0000136987.38729.c0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
42 Crippin J. Bone disease after liver transplantation. Liver Transplantation 2001;7:S27-35. [DOI: 10.1053/jlts.2001.28516] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
43 Byrne DD, Newcomb CW, Carbonari DM, Nezamzadeh MS, Leidl KB, Herlim M, Yang YX, Hennessy S, Kostman JR, Leonard MB, Localio AR, Lo Re V 3rd. Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection. J Hepatol 2014;61:210-8. [PMID: 24713185 DOI: 10.1016/j.jhep.2014.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
44 Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, Kawamura Y, Yatsuji H, Sezaki H, Hosaka T, Ikeda K. Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease. J Med Virol. 2008;80:1302-1307. [PMID: 18461628 DOI: 10.1002/jmv.21195] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
45 Wong GL, Tse YK, Wong VW, Yip TC, Tsoi KK, Chan HL. Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects. Hepatology. 2015;62:684-693. [PMID: 25973979 DOI: 10.1002/hep.27894] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 8.7] [Reference Citation Analysis]
46 Lin J, Hsieh T, Wu C, Chen P, Chueh T, Chang W, Chu H. Association Between Chronic Hepatitis C Virus Infection and Bone Mineral Density. Calcif Tissue Int 2012;91:423-9. [DOI: 10.1007/s00223-012-9653-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
47 Lo Re V 3rd, Guaraldi G, Leonard MB, Localio AR, Lin J, Orlando G, Zirilli L, Rochira V, Kostman JR, Tebas P. Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. AIDS 2009;23:2191-8. [PMID: 19779322 DOI: 10.1097/QAD.0b013e32832ec258] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
48 Bihari C, Lal D, Thakur M, Sukriti S, Mathur D, Patil AG, Anand L, Kumar G, Sharma S, Thapar S, Rajbongshi A, Rastogi A, Kumar A, Sarin SK. Suboptimal Level of Bone-Forming Cells in Advanced Cirrhosis are Associated with Hepatic Osteodystrophy. Hepatol Commun 2018;2:1095-110. [PMID: 30202823 DOI: 10.1002/hep4.1234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
49 Guarino M, Loperto I, Camera S, Cossiga V, Di Somma C, Colao A, Caporaso N, Morisco F. Osteoporosis across chronic liver disease. Osteoporos Int 2016;27:1967-77. [DOI: 10.1007/s00198-016-3512-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
50 Wariaghli G, Allali F, El Maghraoui A, Hajjaj-Hassouni N. Osteoporosis in patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 2010;22:1397-1401. [PMID: 20926953 DOI: 10.1097/meg.0b013e3283405939] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
51 Bai XL, Liang TB, Wu LH, Li DL, Geng L, Wang WL, Shen Y, Zhang M, Zheng SS. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases. Transplant Proc 2007;39:3182-5. [PMID: 18089348 DOI: 10.1016/j.transproceed.2007.06.093] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
52 Wong GL, Seto WK, Wong VW, Yuen MF, Chan HL. Review article: long-term safety of oral anti-viral treatment for chronic hepatitis B. Aliment Pharmacol Ther. 2018;47:730-737. [PMID: 29359487 DOI: 10.1111/apt.14497] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 12.0] [Reference Citation Analysis]
53 Jeong HM, Kim DJ. Bone Diseases in Patients with Chronic Liver Disease. Int J Mol Sci. 2019;20. [PMID: 31480433 DOI: 10.3390/ijms20174270] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
54 Floreani A, Mega A, Camozzi V, Baldo V, Plebani M, Burra P, Luisetto G. Is osteoporosis a peculiar association with primary biliary cirrhosis? World J Gastroenterol 2005;11:5347-50. [PMID: 16149144 DOI: 10.3748/wjg.v11.i34.5347] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
55 Megahed A, Salem N, Fathy A, Barakat T, Alsayed MAEL, Mabood SAE, Zalata KR, Abdalla AF. Pegylated interferon α/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infection. World J Pediatr 2017;13:346-52. [DOI: 10.1007/s12519-017-0013-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
56 Hansen AE, Omland LH, Krarup H, Obel N. Fracture risk in hepatitis C virus infected persons: Results from the DANVIR cohort study. Journal of Hepatology 2014;61:15-21. [DOI: 10.1016/j.jhep.2014.03.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
57 Rudic JS, Giljaca V, Krstic MN, Bjelakovic G, Gluud C. Bisphosphonates for osteoporosis in primary biliary cirrhosis. Cochrane Database Syst Rev. 2011;CD009144. [PMID: 22161446 DOI: 10.1002/14651858.cd009144.pub2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
58 Çetinkaya A, Özen H, Yüce A, Saltık-temizel İN, Demir H, Gürakan F. Bone mineralization in children with Wilson’s disease. Indian J Gastroenterol 2014;33:427-31. [DOI: 10.1007/s12664-014-0468-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
59 Zheng JP, Miao HX, Zheng SW, Liu WL, Chen CQ, Zhong HB, Li SF, Fang YP, Sun CH. Risk factors for osteoporosis in liver cirrhosis patients measured by transient elastography. Medicine (Baltimore) 2018;97:e10645. [PMID: 29768330 DOI: 10.1097/MD.0000000000010645] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
60 Weinreb M, Pollak RD, Ackerman Z. Experimental cholestatic liver disease through bile-duct ligation in rats results in skeletal fragility and impaired osteoblastogenesis. J Hepatol. 2004;40:385-390. [PMID: 15123350 DOI: 10.1016/j.jhep.2003.11.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
61 Moon J, Kallman J, Winter P, Srishord M, Fang Y, Gerber L, Younossi Z. Disparities in Activity Level and Nutrition Between Patients With Chronic Hepatitis C and Blood Donors. PM&R 2012;4:436-41. [DOI: 10.1016/j.pmrj.2012.02.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
62 Sinclair M, Grossmann M, Gow PJ, Angus PW. Testosterone in men with advanced liver disease: Abnormalities and implications: Testosterone in men with liver disease. J Gastroenterol Hepatol 2015;30:244-51. [DOI: 10.1111/jgh.12695] [Cited by in Crossref: 57] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
63 Karoli Y, Karoli R, Fatima J, Manhar M. Study of Hepatic Osteodystrophy in Patients with Chronic Liver Disease. J Clin Diagn Res 2016;10:OC31-4. [PMID: 27656483 DOI: 10.7860/JCDR/2016/21539.8367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
64 Minuk GY, Greenberg R, Uhanova J, Hawkins K, Leslie WD. Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study. Can J Gastroenterol 2009;23:431-6. [PMID: 19543574 DOI: 10.1155/2009/635126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
65 Pusl T, Beuers U. Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy. Clin Rev Allergy Immunol. 2005;28:147-157. [PMID: 15879620 DOI: 10.1385/criai:28:2:147] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
66 O'Neill TJ, Rivera L, Struchkov V, Zaheen A, Thein HH. The effect of HIV-hepatitis C co-infection on bone mineral density and fracture: a meta-analysis. PLoS One 2014;9:e101493. [PMID: 25033046 DOI: 10.1371/journal.pone.0101493] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
67 Baeg MK, Yoon SK, Ko S, Han K, Choi HJ, Bae SH, Choi JY, Choi M. Males seropositive for hepatitis B surface antigen are at risk of lower bone mineral density: the 2008–2010 Korea National Health and Nutrition Examination Surveys. Hepatol Int 2016;10:470-7. [DOI: 10.1007/s12072-015-9672-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
68 Bansal RK, Kumar M, Sachdeva PR, Kumar A. Prospective study of profile of hepatic osteodystrophy in patients with non-choleastatic liver cirrhosis and impact of bisphosphonate supplementation. United European Gastroenterol J 2016;4:77-83. [PMID: 26966526 DOI: 10.1177/2050640615584535] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
69 Casado JL, Bañon S, Andrés R, Perez-Elías MJ, Moreno A, Moreno S. Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients. Osteoporos Int 2014;25:1071-9. [PMID: 24057480 DOI: 10.1007/s00198-013-2506-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
70 Azizieh FY, Shehab D, Jarallah KA, Gupta R, Raghupathy R. Circulatory Levels of RANKL, OPG, and Oxidative Stress Markers in Postmenopausal Women With Normal or Low Bone Mineral Density. Biomark Insights 2019;14:1177271919843825. [PMID: 31452599 DOI: 10.1177/1177271919843825] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
71 Fisher L, Srikusalanukul W, Fisher A, Smith P. Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes. Int J Med Sci 2015;12:100-15. [PMID: 25589886 DOI: 10.7150/ijms.10696] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
72 Moreira RO, Balduíno A, Martins HS, Reis JS, Duarte ME, Farias ML, Borojevic R. Ribavirin, but not interferon alpha-2b, is associated with impaired osteoblast proliferation and differentiation in vitro. Calcif Tissue Int 2004;75:160-8. [PMID: 15148560 DOI: 10.1007/s00223-004-0175-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
73 Chen CH, Lin CL, Kao CH. Association Between Chronic Hepatitis B Virus Infection and Risk of Osteoporosis: A Nationwide Population-Based Study. Medicine (Baltimore) 2015;94:e2276. [PMID: 26683953 DOI: 10.1097/MD.0000000000002276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 4.8] [Reference Citation Analysis]
74 Díez-Ruiz A, García-Saura PL, García-Ruiz P, González-Calvin JL, Gallego-Rojo F, Fuchs D. Bone mineral density, bone turnover markers and cytokines in alcohol-induced cirrhosis. Alcohol Alcohol. 2010;45:427-430. [PMID: 20807717 DOI: 10.1093/alcalc/agq037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
75 Bedimo R, Maalouf NM, Lo Re V 3rd. Hepatitis C virus coinfection as a risk factor for osteoporosis and fracture. Curr Opin HIV AIDS 2016;11:285-93. [PMID: 26890206 DOI: 10.1097/COH.0000000000000259] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
76 Marsano LS, Martin AE, Randall HB. Current nutrition in liver disease. Curr Opin Gastroenterol 2002;18:246-53. [PMID: 17033295 DOI: 10.1097/00001574-200203000-00016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
77 Doustimotlagh AH, Dehpour AR, Etemad-Moghadam S, Alaeddini M, Ostadhadi S, Golestani A. A study on OPG/RANK/RANKL axis in osteoporotic bile duct-ligated rats and the involvement of nitrergic and opioidergic systems. Res Pharm Sci 2018;13:239-49. [PMID: 29853933 DOI: 10.4103/1735-5362.228954] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
78 Yurci A, Kalkan AO, Ozbakir O, Karaman A, Torun E, Kula M, Baskol M, Gursoy S, Yucesoy M, Bayram F. Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease. Eur J Gastroenterol Hepatol. 2011;23:1206-1212. [PMID: 21971374 DOI: 10.1097/meg.0b013e32834cd6f6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
79 Derakhshanian H, Ghadbeigi S, Rezaian M, Bahremand A, Javanbakht MH, Golpaie A, Hosseinzadeh P, Tajik N, Dehpour AR. Quercetin improves bone strength in experimental biliary cirrhosis: Quercetin improves cirrhotic rat bone strength. Hepatology Research 2013;43:394-400. [DOI: 10.1111/j.1872-034x.2012.01075.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]